Provexis plc (AIM:PXS)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 1.052
+0.152 (16.89%)
Oct 22, 2026, 4:28 PM BST
Provexis Revenue
In the fiscal year ending March 31, 2026, Provexis had annual revenue of 1.26M GBP, down -2.14%. Provexis had revenue of 900.16K in the half year ending March 31, 2026, with 117.20% growth. That makes Provexis the 42,677th largest company in the world by revenue and 842nd in the United Kingdom.
Revenue
1.26M
Revenue Growth
-2.14%
P/S Ratio
16.70
Revenue / Employee
632.27K
Employees
2
Market Cap
24.68M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.26M | -27.71K | -2.14% |
| Mar 31, 2025 | 1.29M | 490.28K | 61.13% |
| Mar 31, 2024 | 801.96K | 412.05K | 105.68% |
| Mar 31, 2023 | 389.92K | -36.25K | -8.51% |
| Mar 31, 2022 | 426.17K | -79.16K | -15.67% |
| Mar 31, 2021 | 505.33K | 157.39K | 45.24% |
| Mar 31, 2020 | 347.94K | 25.75K | 7.99% |
| Mar 31, 2019 | 322.19K | 86.39K | 36.63% |
| Mar 31, 2018 | 235.80K | 8.19K | 3.60% |
| Mar 31, 2017 | 227.62K | 135.97K | 148.36% |
| Mar 31, 2016 | 91.65K | 53.43K | 139.77% |
| Mar 31, 2015 | 38.22K | 34.26K | 863.55% |
| Mar 31, 2014 | 3.97K | -33.38K | -89.38% |
| Mar 31, 2013 | 37.35K | -3.44M | -98.93% |
| Mar 31, 2012 | 3.48M | 3.43M | 6,843.78% |
| Mar 31, 2011 | 50.09K | -44.68K | -47.15% |
| Mar 31, 2010 | 94.77K | 69.37K | 273.10% |
| Mar 31, 2009 | 25.40K | -269.95K | -91.40% |
| Mar 31, 2008 | 295.35K | 183.71K | 164.56% |
| Mar 31, 2007 | 111.64K | -423.68K | -79.15% |
| Mar 31, 2006 | 535.32K | -682.01K | -56.03% |
| Mar 31, 2005 | 1.22M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Haleon | 11.15B |
| Hikma Pharmaceuticals | 2.58B |
| HUTCHMED (China) | 413.87M |
| ECO Animal Health Group | 87.53M |
| Allergy Therapeutics | 57.29M |
| Shield Therapeutics | 44.19M |
| Chill Brands Group | 955.18K |
Provexis News
- 4 months ago - AIM Market Roundup: Ramsdens, Provexis, Pulsar Helium - The Armchair Trader
- 11 months ago - AIM Market Roundup: Provexis, Geo Exploration, Sabien - The Armchair Trader